Spica Healthcare — Unit of Grover Hospital, Bathinda
HomeHealth Guides & BlogsOrthopaedic Oncology & Bone TumorsExtremity Soft Tissue Sarcomas: 3D Anatomical Margin Clearance, Neoadjuvant vs. Adjuvant Radiotherapy, and Compartmental Resection
Orthopaedic Oncology & Bone Tumors

Extremity Soft Tissue Sarcomas: 3D Anatomical Margin Clearance, Neoadjuvant vs. Adjuvant Radiotherapy, and Compartmental Resection

11 min read
Sep 12, 2026
Spica Healthcare Clinical & Surgical Protocol Illustration #142

Clinical Summary & Key Takeaways

A masterclass in orthopaedic musculoskeletal oncology on extremity soft tissue sarcomas, evaluating 3D barrier-based margin clearance, STRASS neoadjuvant IMRT sequencing, and complex neurovascular-sparing reconstructive surgery.

CRITICAL CLINICAL RED FLAG: Any soft tissue mass deep to the deep fascia, painful, firm, or larger than 5 cm (golf-ball size) that has been growing for >4 weeks must be treated as a malignant sarcoma until proven otherwise; unplanned 'whoops' excisional biopsies without prior MRI and core biopsy severely compromise limb preservation.

1. Anatomical Barriers & 3D Margin Planning in Soft Tissue Sarcomas

Extremity soft tissue sarcomas (liposarcoma, leiomyosarcoma, undifferentiated pleomorphic sarcoma, synovial sarcoma) originate within mesenchymal muscular compartments. Unlike benign tumors, sarcomas do not possess a true fibrous capsule; rather, they are surrounded by a pseudocapsule of compressed, actively infiltrating malignant cells with satellite microscopic tumor extensions into adjacent tissue planes.

  • Resistant Anatomical Barriers: Intact muscular fascia, periosteum, and epineurium provide dense mechanical barriers against tumor penetration. A 1–2 mm margin across unbreached deep fascia is oncologically equivalent to a 2–3 cm margin through muscular fat planes.

  • Neurovascular Bundle Preservation: Adventitial and epineural micro-dissection under surgical loupe magnification permits R0 resection while preserving major motor and sensory nerves (sciatic, femoral, median).

2. Neoadjuvant vs. Adjuvant Radiotherapy: The STRASS Paradigm

Preoperative (neoadjuvant) intensity-modulated radiation therapy (IMRT 50 Gy in 25 fractions) is the preferred standard for deep, high-grade extremity sarcomas:

  1. Smaller Treatment Volumes: Irradiates only the intact primary tumor rather than extensive post-surgical scar beds, reducing long-term joint fibrosis, lymphedema, and secondary fracture risk.

  2. Sterilization of Pseudocapsule: Induces peripheral fibrous encapsulation and renders microscopic marginal cells non-viable, facilitating safe marginal dissection close to critical nerves and vessels.

"In sarcoma surgery, the first surgical attempt is the definitive attempt. Precise 3D margin planning combined with neoadjuvant IMRT achieves local tumor control rates >95% without compromising functional limb survival." — Dr. Deepak Garg

3. Compartmental Soft Tissue Reconstruction Protocols

Following radical wide resection, immediate reconstructive muscle transposition (latissimus dorsi, rectus abdominis, gastrocnemius rotational flaps, or anterolateral thigh free flaps) restores soft tissue dead space coverage, isolates exposed neurovascular bundles, and provides well-vascularized tissue that prevents post-radiation wound breakdown.

4. Peer-Reviewed References & Clinical Guidelines

1. Gronchi A, Raut CP, Swallow C, et al. Preoperative Radiation Therapy in Extremity Soft Tissue Sarcomas: European Society for Medical Oncology (ESMO) and EURACAN Clinical Practice Guidelines. Annals of Oncology, 2021; 32(11): 1348-1365.

2. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. The Lancet, 2002; 359(9325): 2235-2241.

3. Baldini EH, Lapidus JA, Wang D, et al. Predictors of Local Recurrence and Disease-Free Survival in Extremity Soft Tissue Sarcomas: Results of RTOG 0630. Int J Radiat Oncol Biol Phys, 2017; 98(3): 648-656.

Frequently Asked Patient Questions

Limb Salvage with modular titanium megaprosthesis removes the tumor completely while preserving the limb, allowing patients to walk, work, and maintain full social independence without the physical disability of an artificial limb.

Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Share this medical guide:
WhatsApp
Director-Led Clinical Breakthroughs

Signature Surgical Innovations & Techniques

Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

1 of 13
Comprehensive Bone Cancer Oncology & Limb Preservation
Click to Watch Video Demonstration
95%+ Limb Salvage & MAP Chemotherapy
Multidisciplinary Limb Salvage, MAP Chemotherapy & Modular Megaprosthetics

Comprehensive Bone Cancer Oncology & Limb Preservation

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.

Key Advantages Over Conventional Surgery:
Coordinated Surgical & Medical Oncology: Seamless dual leadership under Dr. Deepak Garg & Dr. Neha Gupta
95%+ Limb Preservation Rate: Wide oncological bone resection avoiding traumatic limb amputations
High-Grade Sarcoma Chemotherapy: Standardized MAP and VIDE protocols delivering high tumor necrosis rates (>90%)
Custom Modular Megaprostheses: Immediate joint restoration with biological tendon ingrowth collars
Why Families & Physicians Trust Spica

World-Class Clinical Precision, Built on Compassion

Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.

AIIMS & Tata Memorial Alumni25+ Yrs Combined Senior Leadership

15,000+ Complex Surgeries & 100% Director-Led Evaluations

Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.

15,000+Surgeries Completed
95%+Limb Salvage Rate
<0.3%Infection Benchmark
Pre-Op 3D Virtual Planning 100% Direct Director OPD Day-1 Walking Protocol
Sub-Millimeter Accuracy

3D Navigated Robotics & Day-1 Walking

Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.

ROSA Robotics & Stryker Nav
Malwa Punjab Exclusive

Limb-Salvage Over Amputation

South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.

Modular Megaprosthesis
0-Out-Of-Pocket Options

100% Cashless PM-JAY & TPAs

Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.

Ayushman + 30+ TPAs Empanelled
24/7 Tertiary Ready

Class-100 Laminar Flow OTs & ICU

Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.

Spica Healthcare Bathinda
Expert Surgical Directors

Meet the Doctors at Spica Healthcare

Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Dr. Neha Gupta

Senior Consultant & Clinical Director — Medical Oncology

13+ Yrs Exp

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Medical Oncology & ChemotherapyImmunotherapy & Targeted OncologyPrecision Oncology & Cancer GenomicsPreventive Cancer ScreeningPalliative & Supportive OncologyHormonal TherapyComprehensive Cancer Treatments
Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Dr. Deepak Garg

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

16+ Yrs Exp

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Orthopaedic Oncology & Bone Tumors3D Robotic Joint ReplacementSports Injuries & ArthroscopyTrauma & Fracture ReconstructionGeneral Orthopaedics & Spine CareComprehensive Cancer Treatments
Community Health & Academic Outreach

Upcoming Health Camps & Academic Events

Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.

Curious what families & patients experience

Hear what our patients are saying

Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.

Health Knowledge & Clinical Guides

Doctor-Authored Health Guides

Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.